OCT 29, 2020 8:15 AM PDT

Skin Deep: A Novel Test for Parkinson's

WRITTEN BY: Tara Fernandez

In Parkinson’s disease (PD), there is chronic degeneration of the central nervous system, particularly in the regions involved with controlling the motor system. As a result, patients experience tremors, rigidity, and difficulties with walking and coordination. Around 60,000 Americans are diagnosed with PD every year and over 10 million people around the world are living with the condition. Diagnosing PD, particularly at the early stages, continues to be a challenge and many are at advanced stages of the disease by the time they seek medical help. 

“The clinical diagnostic accuracy for early-stage PD has been quite poor, only around 50-70%,” said Thomas Beach, a researcher developing new and improved methodologies for diagnosing PD. “And since clinical trials really need to be done at an early stage to avoid further brain damage, they have been critically hampered because they have been including large percentages of people who may not actually have the disease.”

In a recent study, Beach and the team have made a breakthrough: a simple skin test for PD. This chemical assay was designed to detect alpha-synuclein (a protein biomarker present in the brains and other tissues of PD patients) that serves as a positive indicator of the neurodegenerative condition.

The team validated their innovation using 50 skin samples obtained from the study participants, half of which already had a PD diagnosis. Promisingly, the assay correctly diagnosed 96 percent of the PD patients with levels of sensitivity and specificity critical for a robust and accurate diagnostic test.

The skin-based diagnostic test was based on an existing assay originally created for detecting bovine spongiform encephalopathy (BSE), commonly known as mad cow disease. The team from Iowa State University has spent several years building upon this foundation, adapting and optimizing the assay to detect the presence of misfolded proteins, specifically misfolded alpha-synuclein in the case of PD. 

Over time, these misfolded proteins tend to build up and accumulate in brain tissues, resulting in the disruption of neural function. These misfolded proteins don’t just pile up in the brain, however, and can also be found in trace amounts in other anatomical locations, including the skin.

According to the study, earlier detection of PD is a stepping stone towards earlier, more effective clinical intervention as well as improved testing strategies for therapeutics in development.

 

 

Sources: Movement Disorders, Iowa State University.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 15, 2020
Genetics & Genomics
How Dermatitis is Linked to Increased Risk of Food Allergies
AUG 15, 2020
How Dermatitis is Linked to Increased Risk of Food Allergies
Small changes in the genome can sometimes have a huge impact, and researchers have found two that increase the risk of e ...
SEP 02, 2020
Clinical & Molecular DX
Feeling Tired? Scientists Use Brain Scans to Measure Fatigue
SEP 02, 2020
Feeling Tired? Scientists Use Brain Scans to Measure Fatigue
Yawning in the middle of the day is completely normal for people with hectic schedules. How do you know whether it&rsquo ...
SEP 17, 2020
Clinical & Molecular DX
Blood Vessels on a Chip Test Clotting
SEP 17, 2020
Blood Vessels on a Chip Test Clotting
Blood clotting, also known as coagulation, is a critical biological mechanism to prevent excessive blood loss in the eve ...
OCT 13, 2020
Clinical & Molecular DX
Test for Diabetes Checks If the Liver Is Responding
OCT 13, 2020
Test for Diabetes Checks If the Liver Is Responding
Glucagon is a hormone that prevents blood glucose levels from dropping too low by stimulating the liver to convert store ...
OCT 22, 2020
Cardiology
Using Liposomes to Deliver Repair Packages to the Heart
OCT 22, 2020
Using Liposomes to Deliver Repair Packages to the Heart
The secret to any successful drug is not just its ability to treat a disease but its ability to target the disease exclu ...
NOV 17, 2020
Clinical & Molecular DX
Tumor Stiffness Linked to Its Aggressiveness
NOV 17, 2020
Tumor Stiffness Linked to Its Aggressiveness
  As tumors grow, tiny areas at their cores are found to become stiff prior to metastasis, or the spread of cancer ...
Loading Comments...